While CD95 will protect PCa cells against apoptosis, CD59, in turn, may contribute to immune evasion by protecting SSEA-4-positive PCa cells from complement-mediated lysis, thus promoting their therapy resistance and survival. Here, CD59 is linked to posterior cortical atrophy.